NCT06122610 2026-01-15
Using Novel Imaging to More Safely Treat Neuroendocrine Tumors
University of Wisconsin, Madison
Phase 1 Recruiting
Clinical Trials
8 trialsNCT04510311 2025-01-10
Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Completed
NCT03271281 2022-06-30
PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2
Rigshospitalet, Denmark
Phase 2 Completed
NCT03278275 2022-06-30
PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105
Rigshospitalet, Denmark
Phase 2 Completed
NCT04552847 2022-02-17
Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors
Universitaire Ziekenhuizen KU Leuven
Phase 2/3 Completed
NCT03883776 2020-09-09
Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors
Universitaire Ziekenhuizen KU Leuven
Phase 1 Completed
NCT03511768 2018-04-30
A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms
Xiangya Hospital of Central South University
Phase 1/2 Unknown
NCT02621541 2016-01-06
Nonfunctional Pancreatic NET and PET Imaging
Turku University Hospital
Phase 4 Unknown